Bioassociate in the Press
Bioassociate analysts are some of the most experienced professionals in the Israeli life science arena. We frequently provide public insights and opinions on current issues in the field, some of which may be found in this section.
Content Contributions in English
May 24, 2013. Pharmaphorum: Bio-Brand Your Way Through the Valley of Death and Beyond
Apr. 5, 2013. SeekingAlpha: Bioassociate Initiated Coverage on RedHill BioPharma with a Buy
Feb. 28, 2013. SeekingAlpha: Bioassociate Initiated Coverage on KaloBios Pharmaceuticals with a Buy
Feb. 21, 2013. SeekingAlpha: Bioassociate Initiated Coverage on Oramed Pharmaceuticals with a Buy
Dec 3, 2012. SeekingAlpha: BiolineRx is Approaching its Moment of Truth
Sep 4, 2012. SeekingAlpha: Cancer Drug Deals Reaching New Heights
Aug 16, 2012. SeekingAlpha: Is the Hep C Drug Pipeline Beginning to Crack?
Jul 25, 2012. SeekingAlpha: Undervalued Biotech Stocks in Non-US Markets: Part 1
Jul 19, 2012. SeekingAlpha: The race for the next blockbuster Schizophrenia drug
Jul 5, 2012. SeekingAlpha: BioLineRx: Upside greater than predicted by analyst
Jul 4, 2012. SeekingAlpha: 2012 Biotech IPOs: age of the dreamers?
May 2012: NASDAQ-TASE Biomed Conference Introduction written by Bioassociate’s CEO
See the entire conference booklet here
Apr 10, 2012. Globes: Ignorance breeds volatility for life sciences shares
Press releases in Hebrew
Jul 5, 2012. The Marker: Positive review of Roth Capital causes BioLineRx stock to jump 25%
Jul 2, 2012. The Marker: Social Justice and the Pharmaceutical Industry
Dec 21, 2010. Bizportal: Brainsway – the dream getting close to the market
Nov 11, 2010. Bizportal: InsuLine Medical-will it be interesting in the long run
Oct 31, 2010. (Video) Bizportal: Investment potential of Protalix Biotherapeutics
